Understand the concern
Filler safety: Injectable breast enhancement should not be presented as an established safe filler indication.
Specialist Consultation
Understand your options. Make an informed decision.
Discuss your goals with a qualified clinician, including suitability, risks and alternatives.

Breast enhancement enquiries require specialist assessment. Injectable breast fillers should not be presented as an established low-risk alternative to surgery.

Filler safety: Injectable breast enhancement should not be presented as an established safe filler indication.
Specialist assessment should precede any enhancement decision.
US FDA warnings are not a Bangladesh approval assessment; local product and use status need verification.
Discuss filler safety and breast screening.
Review the history and examination findings relevant to breast fillers.
Discuss specialist referral, surgical alternatives, product approval and alternatives.
Confirm the exact method, product or device, risks and cost before agreeing.
Agree how response, recovery and any concerns will be reviewed.
The clinic must confirm timing for the exact breast fillers approach after assessment.
No universal session count is assumed; the diagnosis and proposed method determine a plan.
Recovery depends on the intervention. Ask for written, procedure-specific guidance before booking.
Outcomes vary. Filler safety and your individual assessment affect expectations.
The FDA recommends against injectable fillers for breast enlargement. Risks can be serious; local regulatory status and specialist advice require confirmation.
Seek prompt medical advice for severe or worsening symptoms after a procedure.
Request written care instructions for the exact method proposed.
Do not add medicines or procedures without discussing the plan.
The FDA recommends against injectable fillers for breast enlargement. Risks can be serious; local regulatory status and specialist advice require confirmation.
Contact the clinic about unexpected or worsening symptoms; seek urgent care for severe reactions.
Injectable breast enhancement should not be presented as an established safe filler indication.
Discuss how any prior or proposed intervention could affect examination and screening with a breast specialist.
Specialist assessment should precede any enhancement decision.
Ask about established alternatives and their individual risks without assuming a procedure is needed.
US FDA warnings are not a Bangladesh approval assessment; local product and use status need verification.
Breast enhancement enquiries require specialist assessment. Injectable breast fillers should not be presented as an established low-risk alternative to surgery.
The FDA recommends against injectable fillers for breast enlargement. Risks can be serious; local regulatory status and specialist advice require confirmation.
No fixed course or guaranteed outcome is stated. The plan depends on the confirmed diagnosis, method and individual response.
A quotation requires confirmation of the method, treatment area and individual plan. No unverified price is listed.
Request an appointment through the clinic contact form or call 01704-548130. The clinic is at Islam Tower, 5th Floor, Sukrabad, Dhanmondi 32, opposite Metro Shopping Mall, Dhaka.

Request a private consultation to discuss symptoms, options and suitability.
Learn More →
Request a medical assessment to discuss the procedure, evidence, risks and alternatives.
Learn More →
Discuss your reasons for considering IV therapy and the medical checks required.
Learn More →Book a consultation with Dr. Setu to discuss your concerns and explore appropriate treatment options.
Dr. Setu’s Skin & Aesthetic Center · Islam Tower, 5th Floor, Sukrabad, Dhanmondi 32, opposite Metro Shopping Mall, Dhaka. Plan your visit · 01704-548130
Patient information reference: FDA: dermal fillers. Procedure choice requires clinical assessment.